CME Group Inc

CME has broken decisively below the 275 support cluster in a Stage 4 distribution environment, reinforced by a Support Failure pattern. The medium-term directional bias is bearish, and short-term conditions favor execution now as price fails at the 275–278 EMA resistance zone. While the long-term uptrend above the 200-day SMA remains intact, the immediate risk is further downside toward the 50-day EMA near 268–270. The recommended action is to sell now into the near-term resistance cluster, with a clear invalidation if price reclaims 275–278 and holds.

• ↑July ADV reached 27 M contracts (+23% YoY); equity index ADV up 48%.
• ↑Quarterly dividend of $1.30 per share equates to a 0.92% yield.
• ↓YTD stock down 3.8% vs. S&P 500’s +13.2% underperformance.